rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Adelene Q. Perkins

Director

Company insider

Files Form 4 as: Director, Bruker; Chief Executive Officer, Infinity Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
156
Buys
18
Sells
12
Bought
$1.1M
Sold
$2.6M
Companies
2
Companies where not an officer
1
First trade
12 Sep 2006
Last trade
15 Feb 2026
Last filed
18 Feb 2026

Companies traded

Where they are an officer
Infinity PharmaceuticalsDirector, Officer · last 12 Sep 202318 buys · 12 sells
Everywhere else they filed: board seats, 10% stakes, other companies
BRKR BrukerDirector · Life-science tools · last 15 Feb 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Feb 2026filed 18 Feb 2026BRKR BrukerLife-science toolsSEC FORM 4 Code A—4,520 at $0.00filing
15 Feb 2026filed 18 Feb 2026BRKR BrukerLife-science toolsSEC FORM 4 Code A—4,520 at $0.00filing
15 Feb 2025filed 19 Feb 2025BRKR BrukerLife-science toolsSEC FORM 4 Code A—3,298 at $0.00filing
5 Jan 2024filed 9 Jan 2024BRKR BrukerLife-science toolsSEC FORM 4 Code A—2,377 at $0.00filing
12 Sep 2023filed 12 Sep 2023Infinity PharmaceuticalsSEC FORM 4 Sold$29K410,196 at $0.07filing
9 Sep 2023filed 12 Sep 2023Infinity Pharmaceuticalsoption or derivativeSEC FORM 4 Code M—768,133 at $0.00filing
9 Sep 2023filed 12 Sep 2023Infinity PharmaceuticalsSEC FORM 4 Code M—768,133filing
5 Jan 2023filed 9 Jan 2023BRKR BrukerLife-science toolsSEC FORM 4 Code A—1,970 at $0.00filing
11 Jan 2022filed 12 Jan 2022Infinity Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—576,100 at $0.00filing
5 Jan 2022filed 6 Jan 2022BRKR BrukerLife-science toolsSEC FORM 4 Code A—1,841 at $0.00filing
5 Jan 2021filed 7 Jan 2021BRKR BrukerLife-science toolsSEC FORM 4 Code A—2,302 at $0.00filing
22 Dec 2020filed 23 Dec 2020Infinity Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—485,000 at $0.00filing
10 Jan 2020filed 13 Jan 2020Infinity Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—606,250 at $0.00filing
10 Jan 2020filed 13 Jan 2020Infinity PharmaceuticalsSEC FORM 4 Code A—155,134 at $0.00filing
6 Jan 2020filed 7 Jan 2020BRKR BrukerLife-science toolsSEC FORM 4 Code A—2,472 at $0.00filing
13 Jun 2019filed 14 Jun 2019Infinity Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—242,000 at $0.00filing
7 Jan 2019filed 10 Jan 2019BRKR BrukerLife-science toolsSEC FORM 4 Code A—4,134 at $0.00filing
4 Jan 2019filed 7 Jan 2019Infinity Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—243,000 at $0.00filing
1 Oct 2018filed 2 Oct 2018Infinity PharmaceuticalsSEC FORM 4 Sold$14K5,000 at $2.82filing
5 Mar 2018filed 7 Mar 2018Infinity PharmaceuticalsSEC FORM 4 Sold$14K5,000 at $2.78filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed30

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.